These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3724897)

  • 1. [Carcinogenicity studies in experimental animals. I. Design and performance].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1049-51. PubMed ID: 3724897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carcinogenicity studies in experimental animals. II. Interpretation of the results and significance for man].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1051-4. PubMed ID: 3724898
    [No Abstract]   [Full Text] [Related]  

  • 3. Considerations in the interpretation of animal bioassays for chemical carcinogenicity.
    Griesemer RA
    Transplant Proc; 1984 Apr; 16(2):412-5. PubMed ID: 6372175
    [No Abstract]   [Full Text] [Related]  

  • 4. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of carcinogenicity studies with aldrin and dieldrin.
    Ritper DL
    J Assoc Off Anal Chem; 1979 Jul; 62(4):900-3. PubMed ID: 500539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to "use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity".
    Fears TR; Tarone RE
    J Toxicol Environ Health; 1977 Nov; 3(4):629-32. PubMed ID: 592430
    [No Abstract]   [Full Text] [Related]  

  • 8. Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.
    Guess H; Crump K; Peto R
    Cancer Res; 1977 Oct; 37(10):3475-83. PubMed ID: 908002
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental cancer: animal studies and assay procedures.
    Griffin AC
    Tex Rep Biol Med; 1978; 37():45-9. PubMed ID: 752984
    [No Abstract]   [Full Text] [Related]  

  • 10. Extra-label drug use--veterinary practitioner views: laboratory animals.
    Sojka NJ
    J Am Vet Med Assoc; 1993 May; 202(10):1648-9;discussion 1654-8. PubMed ID: 8514574
    [No Abstract]   [Full Text] [Related]  

  • 11. 2nd International symposium of the Society of Toxicologic Pathologists. Design of carcinogenicity studies: considerations in pathology interpretation. May 9-11, 1983, Arlington, Virginia.
    Toxicol Pathol; 1983; 11(1):28-95. PubMed ID: 6681393
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals.
    Griesemer RA; Cueto C
    IARC Sci Publ; 1980; (27):259-81. PubMed ID: 6893701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A semiparametric model for regression analysis of interval-censored failure time data.
    Finkelstein DM; Wolfe RA
    Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Open Field Test: reinventing the wheel.
    Stanford SC
    J Psychopharmacol; 2007 Mar; 21(2):134-5. PubMed ID: 17329288
    [No Abstract]   [Full Text] [Related]  

  • 15. Monkey smallpox trial suspended over painkiller use.
    Check E
    Nature; 2002 Jul; 418(6895):265. PubMed ID: 12124590
    [No Abstract]   [Full Text] [Related]  

  • 16. Design of cancer assays for pharmaceutical agents.
    Meyers DB; Young SS; Gries CL
    J Natl Cancer Inst; 1985 May; 74(5):1151-2. PubMed ID: 3858583
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of statistics when examining lifetime studies in rodents to detect carcinogenicity.
    Salsburg DS
    J Toxicol Environ Health; 1977 Nov; 3(4):611-28. PubMed ID: 592429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential contamination from feeding test chemicals in carcinogen bioassay research: evaluation of single- and double-corridor animal hospital facilities.
    Sansone EB; Losikoff AM
    Toxicol Appl Pharmacol; 1979 Aug; 50(1):115-21. PubMed ID: 494292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of animal welfare in new housing systems for laying hens within the scope of the animal protection regulation].
    Oester H; Fröhlich E
    Schweiz Arch Tierheilkd; 1986 Oct; 128(10):521-34. PubMed ID: 3787241
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.